Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Early emergence phase of SARS-CoV-2 Delta variant in Florida

View ORCID ProfileEleonora Cella, View ORCID ProfileSobur Ali, Sarah E. Schmedes, Brittany Rife, View ORCID ProfileSimone Marini, Marco Salemi, View ORCID ProfileJason Blanton, View ORCID ProfileTaj Azarian
doi: https://doi.org/10.1101/2022.02.18.22271195
Eleonora Cella
1Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eleonora Cella
Sobur Ali
1Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sobur Ali
Sarah E. Schmedes
2Bureau of Public Health Laboratories, Florida Department of Health, Jacksonville, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brittany Rife
3Emerging Pathogens Institute, University of Florida, Gainesville, FL
4Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Marini
5Department of Epidemiology, University of Florida, Gainesville, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simone Marini
Marco Salemi
3Emerging Pathogens Institute, University of Florida, Gainesville, FL
4Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Blanton
2Bureau of Public Health Laboratories, Florida Department of Health, Jacksonville, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jason Blanton
Taj Azarian
1Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Taj Azarian
  • For correspondence: taj.azarian{at}ucf.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

SARS-CoV-2, the causative agent of COVID-19, emerged in late 2020. The highly contagious B.1.617.2 (Delta) Variant of Concern (VOC) was first identified in October 2020 in India and subsequently disseminated worldwide, later becoming the dominant lineage in the U.S. Despite considerable genomic analysis of SARS-CoV-2 in the U.S., several gaps in the understanding of the local dynamics during early introductions remain, which when elucidated could translate the results of viral genomic epidemiology to actionable mitigation efforts. Here, we explore the early emergence of the Delta variant in Florida, U.S. using phylogenetic analysis of representative Florida and globally sampled genomes. We find multiple independent introductions into Florida primarily from North America and Europe, with a minority originating from Asia. These introductions lead to three distinct clades that demonstrated varying relative rates of transmission and possessed five distinct substitutions that were 3-21 times more prevalent in the Florida sample as compared to the global sample. Our results underscore the benefits of routine viral genomic surveillance to monitor epidemic spread and support the need for more comprehensive genomic epidemiology studies of emerging variants. In addition, we provide a model of epidemic spread of newly emerging VOCs that can inform future public health responses.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded in part by a grant from The Rockefeller Foundation to the University of Florida and the University of Central Florida in order to accelerate regional genomic surveillance. The views and findings are those of the author and not those of the funder (The Rockefeller Foundation). This work was funded in part by Epidemiology and Laboratory Capacity award from the CDC Office of Advanced Molecular Detection to the Florida Department of Health Bureau of Public Health Laboratories.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 22, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Early emergence phase of SARS-CoV-2 Delta variant in Florida
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Early emergence phase of SARS-CoV-2 Delta variant in Florida
Eleonora Cella, Sobur Ali, Sarah E. Schmedes, Brittany Rife, Simone Marini, Marco Salemi, Jason Blanton, Taj Azarian
medRxiv 2022.02.18.22271195; doi: https://doi.org/10.1101/2022.02.18.22271195
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Early emergence phase of SARS-CoV-2 Delta variant in Florida
Eleonora Cella, Sobur Ali, Sarah E. Schmedes, Brittany Rife, Simone Marini, Marco Salemi, Jason Blanton, Taj Azarian
medRxiv 2022.02.18.22271195; doi: https://doi.org/10.1101/2022.02.18.22271195

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (754)
  • Anesthesia (221)
  • Cardiovascular Medicine (3288)
  • Dentistry and Oral Medicine (364)
  • Dermatology (277)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1169)
  • Epidemiology (13358)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5147)
  • Geriatric Medicine (481)
  • Health Economics (782)
  • Health Informatics (3264)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (429)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14622)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (127)
  • Nephrology (522)
  • Neurology (4919)
  • Nursing (262)
  • Nutrition (727)
  • Obstetrics and Gynecology (882)
  • Occupational and Environmental Health (795)
  • Oncology (2519)
  • Ophthalmology (723)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (556)
  • Psychiatry and Clinical Psychology (4205)
  • Public and Global Health (7499)
  • Radiology and Imaging (1704)
  • Rehabilitation Medicine and Physical Therapy (1011)
  • Respiratory Medicine (980)
  • Rheumatology (479)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (205)